Characterization of ceftriaxone-resistant Aeromonas spp. isolates from stool samples of both children and adults in Southern India

Journal of Health, Population, and Nutrition
Maanasa BhaskarJharna Mandal

Abstract

Aeromonas species can cause a wide spectrum of illnesses varying from intestinal to extra intestinal and vary in their susceptibility to different antibiotics. The current study was undertaken to characterize the third generation cephalosporin-resistant strains of Aeromonas spp. which were isolated from stool specimens. Out of a total of 2780 stool samples, 29 Aeromonas spp. were identified, out of which, 9 were resistant to ceftriaxone by the Kirby-Bauer antibiotic testing method. These strains were subjected to minimum inhibitory concentration (MIC) determination by agar dilution for ceftriaxone. Phenotypic and genotypic testing of AmpC beta-lactamase and extended spectrum beta-lactamase (ESBL) were performed. Gene transfer was carried out to demonstrate transmissibility of these genetic elements by conjugation experiments. Out of the 29 strains, 9 showed MIC of ≥4 μg/ml. Seven out of 9 showed presence of blaCTX-M, while 2 more strains showed the presence of inducible AmpC beta-lactamase and presence of MOX gene. Gene transfer experiments showed that these elements were transmissible to recipient (Escherichia coli J53 strain) in the presence of ceftriaxone. Dissemination of these resistance determinants like plasmids is pivot...Continue Reading

References

Feb 1, 1982·The Journal of Infectious Diseases·H ChampsaurP Auzepy
Jan 5, 2000·Applied and Environmental Microbiology·M Goñi-UrrizaC Quentin
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B EssersM G Bianchetti
May 31, 2002·Journal of Clinical Microbiology·F Javier Pérez-Pérez, Nancy D Hanson
May 10, 2003·Emerging Infectious Diseases·Jordi VilaJoaquin Gascon
Nov 6, 2004·Journal of Clinical Microbiology·Seonghan KimBokkwon Lee
Feb 9, 2008·Emerging Infectious Diseases·Vincent CattoirPatrice Nordmann
Apr 17, 2008·The Journal of Antimicrobial Chemotherapy·Laurence GordonEtienne Giraud
Sep 6, 2008·The Journal of Antimicrobial Chemotherapy·Renata Cristina PicãoPatrice Nordmann
Jan 13, 2009·Clinical Microbiology Reviews·George A Jacoby
Aug 29, 2009·Journal of Medical Microbiology·Poulami BhowmikT Ramamurthy
Jan 13, 2010·Clinical Microbiology Reviews·J Michael Janda, Sharon L Abbott
Nov 4, 2010·Journal of Infection in Developing Countries·Jharna MandalSubhash C Parija

❮ Previous
Next ❯

Datasets Mentioned

BETA
FJ997868.1
FJ262599.1

Methods Mentioned

BETA
PCR
electrophoresis
PCRs

Software Mentioned

BLASTN

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.